Press Release

Next Generation Sequencing Services Market to be dominated by the Growing Incidences of Genetic Disorders Through 2028.

Increasing prevalence of genetic disorders and advancements in genomic technologies is expected to drive the growth of Global Next Generation Sequencing Services Market in the forecast period.

According to TechSci Research report, Next Generation Sequencing Services Market –Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028, Next Generation Sequencing Services Market is expected to grow during the forecast period of 2024-2028. This can be ascribed in the forecasted years due to advancements in genomic technologies, increasing demand for precision medicine, growing application of next generation sequencing in clinical research, and increasing prevalence of genetic disorders.

Whole exome sequencing (WES) is increasingly being used in research and clinical settings for identifying disease-causing mutations. This has led to a growing demand for WES services, which is expected to drive the growth of the NGS services market in the coming years.

These tests enable rapid and accurate identification of the virus and its variants, enabling governments and healthcare organizations to control the spread of the disease.

Furthermore, the pandemic has highlighted the importance of NGS technology in healthcare and research. Governments and healthcare organizations worldwide have recognized the need to invest in NGS technology to prepare for future pandemics and to improve healthcare outcomes.

 

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Next Generation Sequencing Services Market"

 

Global Next Generation Sequencing Services Market can be segmented based on service, workflow, end user, and region.

Global Next Generation Sequencing Services Market can be divided into categories: human genome sequencing services, single cell sequencing services, microbial genome-based sequencing services, gene regulation services, others, based on service. Human genome sequencing services are expected to dominate the market of Next Generation Sequencing (NGS) in the coming years due to several factors. The demand for human genome sequencing is increasing rapidly due to the growing interest in personalized medicine, precision medicine, and genetic research. As a result, human genome sequencing services are expected to be in high demand in the coming years. The decreasing cost of NGS technology has made human genome sequencing more affordable and accessible to individuals and researchers. This has led to a rise in the number of human genome sequencing projects worldwide. In addition, the development of cloud-based computing platforms and bioinformatics tools has made it easier to analyze human genome sequencing data, leading to new discoveries and improved patient outcomes. The growing demand for direct-to-consumer (DTC) genetic testing is expected to drive the growth of the human genome sequencing services market. DTC genetic testing allows individuals to access their genetic information, providing insights into their ancestry, predisposition to certain diseases, and potential responses to different medications.

Global Next Generation Sequencing Services Market is divided into hospitals & clinics, academic & research institutions, pharmaceutical & biotechnology companies, others, based on end user. Pharmaceutical & Biotechnology companies are expected to dominate the Next Generation Sequencing (NGS) market in the coming years due to several factors. NGS technology is being used in drug discovery to identify new drug targets and to understand the genetic basis of disease. NGS is being used in clinical trials to identify biomarkers that can predict drug efficacy and patient response to treatment. As a result, pharmaceutical and biotechnology companies are investing heavily in NGS technology to improve their drug discovery and development pipelines.

Major companies operating in Global Next Generation Sequencing Services Market are:

  • Quest Diagnostics Incorporated
  • Applied Biological Materials, Inc.
  • Novogene Co, Ltd.
  • Azenta Life Sciences (GENEWIZ)
  • NanoString Technologies, Inc.
  • Illumina, Inc.
  • PacBio, Inc.
  • Gene by Gene Ltd
  • Lucigen Corporation

Download Free Sample Report

Customers can also request for 10% free customization on this report.

 

“The Next Generation Sequencing (NGS) Market is experiencing rapid growth and is expected to continue to do so in the coming years. NGS technology has revolutionized genomics research and has numerous applications in fields such as drug discovery, clinical diagnostics, and personalized medicine. The increasing prevalence of genetic disorders and cancer, growing demand for precision medicine, and decreasing cost of NGS technology are driving the market's growth. Additionally, the COVID-19 pandemic has accelerated the adoption of NGS technology in COVID-19 research and diagnostics, further boosting the market's growth. Key players in the NGS market include Illumina, Novogene, and Lucigen Corporation.” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.

Next Generation Sequencing Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Service (Human Genome Sequencing Services, Single Cell Sequencing Services, Microbial Genome-based Sequencing Services, Gene Regulation Services, Others), By Workflow (Pre-Sequencing, Sequencing, Data Analysis), By End User (Hospitals & Clinics, Academic & Research Institutions, Pharmaceutical & Biotechnology Companies, Others), Region and Competition”, has evaluated the future growth potential of Global Next Generation Sequencing Services Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Next Generation Sequencing Services Market.

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656

Email: [email protected]

Web:  https://www.techsciresearch.com

Relevant News